Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
Stopped Investigator left the institute.
Conditions
- Intraocular Melanoma
- Malignant Conjunctival Neoplasm
Interventions
- DRUG: cyclophosphamide
- DRUG: lenalidomide
- DRUG: sunitinib malate
Sponsor
National Institutes of Health Clinical Center (CC)
Collaborators